sb.scorecardresearch
Advertisement

Published 21:08 IST, December 16th 2020

BBL's Covaxin's phase-1 trial's interim findings indicate vaccine 'well-tolerated'

Interim findings from phase-1 trials of BBL's 'Covaxin' was well-tolerated in all dose groups with no serious adverse events, as it awaits DGCI's emergency nod

Follow: Google News Icon
  • share
Covaxin
null | Image: self
Advertisement

21:08 IST, December 16th 2020